Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Miebo™ (perfluorohexyloctane) – New drug approval
May 18, 2023 - Bausch & Lomb announced the FDA approval of Miebo (perfluorohexyloctane), for the treatment of the signs and symptoms of dry eye disease (DED).
